ONM-400

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameONM-400
Drug Alias NameONM-400
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-2 stimulants
TargetsInterleukin-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOnconano Medicine Inc
China Registration ClassN/A

Develop Information

Active CompaniesOnconano Medicine Inc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A